Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Immune and tissue cell targets" is not a canonical term for a single molecule, receptor, or protein; instead, it generally refers to a diverse group of immune cells (such as T cells, B cells, macrophages, mast cells, natural killer cells, etc.) that reside or operate within tissues and can be modulated for therapeutic purposes[1][5][6]. These cells perform a range of functions, including regulating tissue homeostasis, mediating local immune responses, defending against pathogens, and contributing to repair and inflammation[1][6]. In biomedical research and drug development, 'immune and tissue cell targets' may refer to the broad concept of targeting these cell types for therapy, rather than targeting a specific molecule or receptor.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Immune and tissue cell targets.